Commitment to differentiation and expression of early differentiation markers in murine keratinocytes in vitro are regulated independently of extracellular calcium concentrations.

PubWeight™: 0.94‹?› | Rank: Top 15%

🔗 View Article (PMC 2200160)

Published in J Cell Biol on November 01, 1993

Authors

V Drozdoff1, W J Pledger

Author Affiliations

1: Department of Cell Biology, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

Articles cited by this

Calcium regulation of growth and differentiation of mouse epidermal cells in culture. Cell (1980) 8.10

Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal culture and serum-free serial culture. J Invest Dermatol (1983) 5.05

p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA (1988) 4.89

Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions. Cell (1979) 4.38

Regulation of terminal differentiation of cultured human keratinocytes by vitamin A. Cell (1981) 3.61

Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J (1991) 3.56

Terminal differentiation of cultured human epidermal cells. Cell (1977) 3.39

Differentiation of the epidermal keratinocyte in cell culture: formation of the cornified envelope. Cell (1976) 3.30

Expression of murine epidermal differentiation markers is tightly regulated by restricted extracellular calcium concentrations in vitro. J Cell Biol (1989) 3.21

Epidermal differentiation: the bare essentials. J Cell Biol (1990) 3.11

Fibronectin inhibits the terminal differentiation of human keratinocytes. Nature (1989) 2.77

Retinoids as important regulators of terminal differentiation: examining keratin expression in individual epidermal cells at various stages of keratinization. J Cell Biol (1987) 2.62

Cell shape controls terminal differentiation of human epidermal keratinocytes. Proc Natl Acad Sci U S A (1988) 2.53

Classification of epidermal keratins according to their immunoreactivity, isoelectric point, and mode of expression. J Cell Biol (1984) 2.48

Stratification and terminal differentiation of cultured epidermal cells. Nature (1982) 2.44

Changes in keratinocyte adhesion during terminal differentiation: reduction in fibronectin binding precedes alpha 5 beta 1 integrin loss from the cell surface. Cell (1990) 2.19

Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol (1981) 2.14

Clonal growth of normal human epidermal keratinocytes in a defined medium. J Cell Physiol (1982) 2.05

The role of keratin subfamilies and keratin pairs in the formation of human epidermal intermediate filaments. J Cell Biol (1986) 2.04

Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol (1983) 1.94

Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res (1974) 1.94

Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell cycle studies. J Cell Physiol (1984) 1.81

Keratin gene expression in mouse epidermis and cultured epidermal cells. Proc Natl Acad Sci U S A (1983) 1.64

Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. Differentiation (1987) 1.62

Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol (1983) 1.58

Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C. J Cell Biol (1993) 1.54

Terminal differentiation of epidermal keratinocytes. Curr Opin Cell Biol (1989) 1.50

Calcium regulation of growth and differentiation of normal human keratinocytes: modulation of differentiation competence by stages of growth and extracellular calcium. J Cell Physiol (1990) 1.44

Organization of desmosomal plaque proteins in cells growing at low calcium concentrations. J Cell Biol (1988) 1.38

Ultrastructural localization of calcium in psoriatic and normal human epidermis. Arch Dermatol (1991) 1.37

Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol (1990) 1.32

Cytokeratin expression in squamous metaplasia of the human uterine cervix. Differentiation (1986) 1.29

TGF-beta and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells. Cell Regul (1990) 1.28

Early signals for keratinocyte differentiation: role of Ca2+-mediated inositol lipid metabolism in normal and neoplastic epidermal cells. Carcinogenesis (1988) 1.26

Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res (1988) 1.17

Two functionally distinct classes of growth arrest states in human prokeratinocytes that regulate clonogenic potential. J Invest Dermatol (1986) 1.05

Profilaggrin, a high-molecular-weight precursor of filaggrin in human epidermis and cultured keratinocytes. J Invest Dermatol (1985) 1.03

Biologic mechanisms for the regulation of normal human keratinocyte proliferation and differentiation. Am J Pathol (1988) 1.02

Control of growth and differentiation in vitro of human keratinocytes cultured in serum-free medium. Arch Dermatol (1987) 0.99

Keratin gene expression in mouse skin tumors and in mouse skin treated with 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1985) 0.96

Keratin biosynthesis in normal mouse epithelia and in squamous cell carcinomas. mRNA-dependent alterations of the primary structure of distinct keratin subunits in tumors. J Biol Chem (1983) 0.96

Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes. Mol Endocrinol (1990) 0.94

Mitogens induce calcium transients in both dividing and terminally differentiating keratinocytes. J Cell Sci (1991) 0.91

Cellular response to platelet-derived growth factor (PDGF)-AB after down-regulation of PDGF alpha-receptors. Evidence that functional binding does not require alpha-receptors. J Biol Chem (1991) 0.90

Transforming growth factor alpha induces collagen degradation and cell migration in differentiating human epidermal raft cultures. Cell Regul (1991) 0.90

Identification of control elements 3' to the human keratin 1 gene that regulate cell type and differentiation-specific expression. J Biol Chem (1993) 0.90

Terminal differentiation in keratinocytes involves positive as well as negative regulation by retinoic acid receptors and retinoid X receptors at retinoid response elements. Mol Cell Biol (1992) 0.88

Keratinocyte transglutaminase: regulation and release. Adv Exp Med Biol (1988) 0.84

Specific alterations in keratin biosynthesis in mouse epidermis in vivo and in explant culture following a single exposure to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Cancer Res (1987) 0.84

Cell cycle-dependent gene expression in V point-arrested BALB/c-3T3 cells. J Cell Physiol (1993) 0.81

A surgical care study. NATNEWS (1984) 0.77

Lectin binding as a probe of proliferative and differentiative phases in primary monolayer cultures of cutaneous keratinocytes. Exp Cell Res (1988) 0.77

Articles by these authors

Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci U S A (1977) 5.20

Dual control of cell growth by somatomedins and platelet-derived growth factor. Proc Natl Acad Sci U S A (1979) 4.32

Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis. Proc Natl Acad Sci U S A (2001) 3.29

Platelet-derived growth factor induces rapid and sustained tyrosine phosphorylation of phospholipase C-gamma in quiescent BALB/c 3T3 cells. Mol Cell Biol (1989) 2.78

An ordered sequence of events is required before BALB/c-3T3 cells become committed to DNA synthesis. Proc Natl Acad Sci U S A (1978) 2.71

Isoleucine and valine metabolism in Escherichia coli. XXII. A pleiotropic mutation affecting induction of isomeroreductase activity. J Bacteriol (1973) 2.31

Platelet-derived growth factor-induced alterations in vinculin and actin distribution in BALB/c-3T3 cells. J Cell Biol (1985) 2.26

Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells. Exp Cell Res (1982) 2.13

Isoleucine and valine metabolism in Escherichia coli. XX. Multiple forms of acetohydroxy acid synthetase. Biochem Biophys Res Commun (1972) 2.07

Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling. Oncogene (2000) 2.06

Regulation of the cell cycle machinery by oncogenic ras. Oncogene (1996) 1.92

Platelet-derived growth factor-modulated proteins: constitutive synthesis by a transformed cell line. Proc Natl Acad Sci U S A (1981) 1.90

Transforming viruses directly reduce the cellular growth requirement for a platelet derived growth factor. J Cell Physiol (1978) 1.79

Isoleucine and valine metabolism in Escherichia coli. XXI. Mutations affecting derepression and valine resistance. J Bacteriol (1973) 1.75

Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Oncogene (2000) 1.75

Repression of p27kip1 synthesis by platelet-derived growth factor in BALB/c 3T3 cells. Mol Cell Biol (1996) 1.66

Neurotrophic protein S100 beta stimulates glial cell proliferation. Proc Natl Acad Sci U S A (1991) 1.40

Epidermal growth factor (EGF) is required only during the traverse of early G1 in PDGF stimulated density-arrested BALB/c-3T3 cells. Exp Cell Res (1983) 1.36

Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C. Proc Natl Acad Sci U S A (1984) 1.30

Interferon inhibits the establishment of competence in Go/S-phase transition. Science (1986) 1.26

Control of the Balb/c-3T3 cell cycle by nutrients and serum factors: analysis using platelet-derived growth factor and platelet-poor plasma. J Cell Physiol (1979) 1.24

A model of cell cycle control: sequential events regulated by growth factors. Mol Cell Endocrinol (1983) 1.23

Activation of Stat3 preassembled with platelet-derived growth factor beta receptors requires Src kinase activity. Oncogene (2000) 1.16

Modulation of the epidermal growth factor receptor by platelet-derived growth factor and choleragen: effects on mitogenesis. Proc Natl Acad Sci U S A (1982) 1.16

Mitogenic activity elaborated by macrophage-like cell lines acts as competence factor(s) for BALB/c 3T3 cells. J Cell Physiol (1982) 1.15

P27Kip1 and p21Cip1 are not required for the formation of active D cyclin-cdk4 complexes. Mol Cell Biol (2003) 1.14

Epidermal growth factor stimulates formation of inositol phosphates in BALB/c/3T3 cells pretreated with cholera toxin and isobutylmethylxanthine. J Biol Chem (1988) 1.10

Sequential addition of platelet factor and plasma to BALB/c 3T3 fibroblast cultures stimulates somatomedin-C binding early in cell cycle. Proc Natl Acad Sci U S A (1980) 1.10

Growth factor regulation of cyclin D1 mRNA expression through protein synthesis-dependent and -independent mechanisms. Mol Biol Cell (1993) 1.09

Persistence of the mitogenic response to platelet-derived growth factor (competence) does not reflect a long-term interaction between the growth factor and the target cell. J Cell Biol (1983) 1.05

Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene (2000) 1.02

Macrophage-derived growth factor for fibroblasts and Interleukin-1 are distinct entities. J Leukoc Biol (1984) 1.02

Inhibition of mitogenesis in Balb/c-3T3 cells by Trichostatin A. Multiple alterations in the induction and activation of cyclin-cyclin-dependent kinase complexes. J Biol Chem (2000) 1.02

p27Kip1 regulates T cell proliferation. J Biol Chem (2001) 1.02

Identification of the cellular mechanisms responsible for platelet-derived growth factor induced alterations in cytoplasmic vinculin distribution. J Cell Physiol (1986) 1.02

Cyclic adenosine 3':5'-monophosphate phosphodiesterase. Distinct forms in human lymphocytes and monocytes. J Biol Chem (1976) 0.99

Paradigms of growth control: relation to Cdk activation. Sci STKE (2002) 0.98

Regulation of the Balb/c-3T3 cell cycle-effects of growth factors. J Supramol Struct (1980) 0.98

Analysis of cyclin D3-cdk4 complexes in fibroblasts expressing and lacking p27(kip1) and p21(cip1). Mol Cell Biol (2000) 0.98

Differential modulation of G1 cyclins and the Cdk inhibitor p27kip1 by platelet-derived growth factor and plasma factors in density-arrested fibroblasts. J Biol Chem (1996) 0.96

PCNA interacts with hHus1/hRad9 in response to DNA damage and replication inhibition. Oncogene (2000) 0.95

Platelet-derived growth factor modulates epidermal growth factor receptors by a mechanism distinct from that of phorbol esters. Proc Natl Acad Sci U S A (1986) 0.94

The role of p27kip1 in the in vitro differentiation of murine keratinocytes. Cell Growth Differ (1997) 0.93

Association of platelet-derived growth factor-induced protein with nuclear material. Nature (1984) 0.93

Expression and growth inhibitory effect of decapentaplegic Vg-related protein 6: evidence for a regulatory role in keratinocyte differentiation. Proc Natl Acad Sci U S A (1994) 0.92

The role of cyclin D3-dependent kinase in the phosphorylation of p130 in mouse BALB/c 3T3 fibroblasts. J Biol Chem (1998) 0.92

Cyclin D3-associated kinase activity is regulated by p27kip1 in BALB/c 3T3 cells. Mol Biol Cell (1998) 0.91

Accumulation of p53 and reductions in XIAP abundance promote the apoptosis of prostate cancer cells. Cancer Res (2005) 0.91

Cellular response to platelet-derived growth factor (PDGF)-AB after down-regulation of PDGF alpha-receptors. Evidence that functional binding does not require alpha-receptors. J Biol Chem (1991) 0.90

p107 and p130 associated cyclin A has altered substrate specificity. J Biol Chem (1997) 0.88

Serum modification of cyclic nucleotide phosphodiesterase forms independent of protein synthesis. Biochem Biophys Res Commun (1976) 0.88

Differential sensitivity of fibroblasts to epidermal growth factor is related to cyclic AMP concentration. J Cell Physiol (1984) 0.88

Control of late G0/G1 progression and protein modification by SmC/IGF I. Am J Physiol (1987) 0.88

Cellular mechanisms regulating proliferation. Adv Second Messenger Phosphoprotein Res (1988) 0.87

Induction of NF-kappa B-like activity by platelet-derived growth factor in mouse fibroblasts. Mol Biol Cell (1992) 0.87

Cell cycle control: a complex issue. Cell Cycle (2004) 0.87

Density-dependent growth inhibition of fibroblasts ectopically expressing p27(kip1). Mol Biol Cell (2000) 0.87

Role of Gadd45alpha in the density-dependent G1 arrest induced by p27(Kip1). Oncogene (2003) 0.87

Increases in cyclic AMP potentiate competence formation in BALB/c-3T3 cells. J Cell Physiol (1982) 0.86

STAT3 activation accompanies keratinocyte differentiation. Cell Growth Differ (1998) 0.86

Cyclic AMP potentiates down regulation of epidermal growth factor receptors by platelet-derived growth factor. Biochem Biophys Res Commun (1982) 0.85

Regulation of cyclin E and p27kip during mitosis in BALB/c 3T3 cells. Cell Growth Differ (1995) 0.85

Activation of mammalian cyclic AMP phosphodiesterases by trypsin. Biochim Biophys Acta (1978) 0.84

PDGF stimulates transient phosphorylation of 180,000 dalton protein. J Cell Biochem (1985) 0.83

A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation. Oncogene (2011) 0.83

Elevated intracellular concentrations of cyclic AMP inhibited serum-stimulated, density-arrested BALB/c-3T3 cells in mid G1. J Cell Biochem (1982) 0.82

Inhibition of BALB/c-3T3 cells in late G1: commitment to DNA synthesis controlled by somatomedin C. J Cell Physiol (1981) 0.82

The regulation of cell proliferation by serum growth factors. Ann N Y Acad Sci (1982) 0.82

Induction of expression of c-fos and c-myc protooncogenes by basic calcium phosphate crystal: effect of beta-interferon. Cancer Res (1989) 0.82

Cell cycle-dependent gene expression in V point-arrested BALB/c-3T3 cells. J Cell Physiol (1993) 0.81

Sonication as a tool for the study of adenylyl cyclase activity. J Cyclic Nucleotide Res (1977) 0.81

Effects of growth conditions on cyclic nucleotide phosphodiesterases of cultured fibroblasts. J Cyclic Nucleotide Res (1975) 0.81

Cell cycle dependent growth factor regulation of gene expression. J Cell Physiol (1989) 0.81

Molecular mechanism of basic calcium phosphate crystal-induced mitogenesis. Role of protein kinase C. J Biol Chem (1989) 0.80

Primary keratinocytes have an adhesion dependent S phase checkpoint that is absent in immortalized cell lines. Oncogene (1998) 0.80

Apoptosis of osteosarcoma cultures by the combination of the cyclin-dependent kinase inhibitor SCH727965 and a heat shock protein 90 inhibitor. Cell Death Dis (2013) 0.80

Mitogenic response to epidermal growth factor (EGF) modulated by platelet-derived growth factor in cultured fibroblasts. Exp Cell Res (1983) 0.80

Characterization of growth factor-modulated events regulating cellular proliferation. Methods Enzymol (1987) 0.79

Separation of multiple forms of cyclic nucleotide phosphodiesterases from rat brain by isoelectrofocusing. Biochim Biophys Acta (1974) 0.79

Effect of ouabain on growth regulation by serum components in Balb/c-3T3 cells: inhibition of entry into S phase by decreased protein synthesis. J Cell Physiol (1980) 0.78

Detergent solubility defines an alternative itinerary for a subpopulation of PDGF beta receptors. J Cell Physiol (1996) 0.78

Biochemical and functional discrimination of platelet-derived growth factor alpha and beta receptors in BALB/c-3T3 cells. J Biol Chem (1991) 0.78

Rapid induction of competence formation is PDGF-isoform specific. J Cell Biochem (1992) 0.78

Isolation of an activator of multiple forms of cyclic nucleotides phosphodiesterase of rat cerebrum by isoelectric focusing. Biochim Biophys Acta (1975) 0.77

Characterization of cyclic nucleotide phosphodiesterases with multiple separation techniques. Arch Biochem Biophys (1976) 0.77

Heterologous regulation of EGF receptors in fibroblastic cells. J Cell Biochem (1987) 0.77

Selective interferon-alpha/beta effects on platelet-derived growth factor-stimulated processes in quiescent BALB/c-3T3 fibroblasts. J Interferon Res (1994) 0.77

Modulation of the platelet-derived growth factor induced replicative response. J Cell Physiol (1985) 0.76

Cyclic AMP agonists induce the phosphorylation of phospholipase C-tau and of a 76 kDa protein co-precipitated by anti-(phospholipase C-tau) monoclonal antibodies in BALB/c-3T3 cells. Relationship to inositol phosphate formation. Biochem J (1990) 0.76

Regulation of the mammalian fibroblast cell cycle by a platelet-derived growth factor. Prog Clin Biol Res (1979) 0.75

Platelet-derived growth factor (PDGF)-AB-mediated phosphorylation of PDGF beta receptors. Biochem J (1994) 0.75

Identification of platelet-derived growth factor-modulated proteins. Methods Enzymol (1987) 0.75

Regulation of uridine kinase activity in BALB/C-3T3 cells by serum components. In Vitro (1981) 0.75

Platelet-derived growth factor stimulated mechanisms of glucosamine incorporation. Am J Physiol (1987) 0.75

Interdependence of cdk2 activation and interleukin-2Ralpha accumulation in T cells. J Biol Chem (2001) 0.75

Mammalian cell proliferation is regulated by the synergistic actions of multiple growth factors. Adv Exp Med Biol (1981) 0.75

Regulation of cyclic nucleotide phosphodiesterase forms by serum and insulin in cultured fibroblasts. J Cell Physiol (1979) 0.75

Permanent growth arrest in irradiated human fibroblasts. Radiat Res (2001) 0.75

Macromolecular synthesis and stability in growth-arrested BALB/c-3T3 cells. J Cell Biochem (1982) 0.75